US5165441032
© Globe Newswire
02.01.2026
LNTH
LISTED
NASDAQ
Lantheus Announces Closing of SPECT Business Sale to SHINE Technologies
News Preview
BEDFORD, Mass., Jan. 02, 2026 (GLOBE NEWSWIRE) -- Lantheus Holdings, Inc. (“Lantheus” or the “Company”) (NASDAQ: LNTH), the leading radiopharmaceutical-focused company dedicated to helping clinicians Find, Fight, and Follow disease to deliver better patient outcomes, today announced it has completed the previously announced sale of its single pho...
Themefolio
Profiler
Peergroup
© Globe Newswire
24.11.2025
LNTH
LISTED
NASDAQ
Lantheus to Present Florbetaben F 18 Data at CTAD 2025
News Preview
BEDFORD, Mass., Nov. 24, 2025 (GLOBE NEWSWIRE) -- Lantheus Holdings, Inc. (the Company) (NASDAQ: LNTH), the leading radiopharmaceutical-focused company committed to enabling clinicians to Find, Fight and Follow disease to deliver better patient outcomes, announced the presentation of new florbetaben F18 data at the upcoming Clinical Trials on Alz...
Themefolio
Profiler
Peergroup
© BusinessWire
10.11.2025
LNTH
LISTED
NASDAQ
LNTH FINAL DEADLINE ALERT: Faruqi & Faruqi, LLP Announces that Lantheus Investors Have Opportunity to Lead Class Action Lawsuit
News Preview
Faruqi & Faruqi, LLP, a leading national securities law firm, is investigating potential claims against Lantheus Holdings, Inc. (“Lantheus” or the “Company”) (NASDAQ: LNTH) and reminds investors of the November 10, 2025 deadline to seek the role of lead plaintiff in a federal securities class action that has been filed against the Company.
F...
Themefolio
Profiler
Peergroup
Worth to know
20.10.2025
Short Selling Radar
USA, Europe, Asia
Track Short Selling Activities worldwide
Knowing what matters
Leerverkaufsstatistiken, Hedge-Fund Aktivitäten und viele weitere nutzerwertige Informationen benutzerfreundlich aufbereitet
© BusinessWire
07.11.2025
LNTH
LISTED
NASDAQ
Deadline Soon: Lantheus Holdings, Inc. (LNTH) Shareholders Who Lost Money Urged To Contact The Law Offices of Frank R. Cruz About Securities Fraud Lawsuit
News Preview
The Law Offices of Frank R. Cruz reminds investors of the upcoming November 10, 2025 deadline to participate as a lead plaintiff in the securities fraud class action lawsuit filed on behalf of investors who acquired Lantheus Holdings, Inc. (“Lantheus” or the “Company”) (NASDAQ: LNTH) securities between February 26, 2025 and August 5, 2025, inclusi...
Themefolio
Profiler
Peergroup
Swarmalpha i/o · The Event Futures Prediction X
20.10.2025
© BusinessWire
06.11.2025
LNTH
LISTED
NASDAQ
SHAREHOLDER INVESTIGATION: Faruqi & Faruqi, LLP Examining Potential Securities Law Violations at Lantheus
News Preview
Faruqi & Faruqi, LLP, a leading national securities law firm, is investigating potential claims against Lantheus Holdings, Inc. (“Lantheus” or the “Company”) (NASDAQ: LNTH).
Faruqi & Faruqi is a leading national securities law firm with offices in New York, Pennsylvania, California and Georgia. The firm has recovered hundreds of millions...
Themefolio
Profiler
Peergroup
© Globe Newswire
06.11.2025
LNTH
LISTED
NASDAQ
Lantheus Reports Third Quarter 2025 Financial Results and Provides Business Update
News Preview
BEDFORD, Mass., Nov. 06, 2025 (GLOBE NEWSWIRE) -- Lantheus Holdings, Inc. (Lantheus or the Company) (NASDAQ: LNTH), the leading radiopharmaceutical-focused company committed to enabling clinicians to Find, Fight and Follow disease to deliver better patient outcomes, today reported financial results for its third quarter ended September 30, 2025....
Themefolio
Profiler
Peergroup
© BusinessWire
30.10.2025
LNTH
LISTED
NASDAQ
Johnson Fistel Announces Class Action Lawsuit Against Lantheus Holdings, Inc. (LNTH) on Behalf of Investors
News Preview
Johnson Fistel, PLLP announces that a class action lawsuit has commenced on behalf of investors of Lantheus Holdings, Inc. (NASDAQ: LNTH). The lawsuit seeks to recover losses on behalf of investors who purchased the Company’s securities between February 26, 2025 and August 5, 2025, inclusive (the “Class Period”).
What if I purchased Lantheus sec...
Themefolio
Profiler
Peergroup
© Globe Newswire
28.10.2025
LNTH
LISTED
NASDAQ
Lantheus Announces FDA Acceptance of New Drug Application for MK-6240, a PET Imaging Agent Targeting Tau in Alzheimer’s Disease
News Preview
PDUFA Date Set for August 13, 2026 PDUFA Date Set for August 13, 2026...
Themefolio
Profiler
Peergroup
© Globe Newswire
23.10.2025
LNTH
LISTED
NASDAQ
Lantheus to Host Third Quarter 2025 Earnings Conference Call and Webcast on November 6, 2025, at 8:00 a.m. Eastern Time
News Preview
BEDFORD, Mass., Oct. 23, 2025 (GLOBE NEWSWIRE) -- Lantheus Holdings, Inc. (the “Company”) (NASDAQ: LNTH) today announced that it will host a conference call and webcast at 8:00 a.m. ET on Thursday, November 6, 2025, to discuss its financial results and provide a business update for the third quarter of 2025....
Themefolio
Profiler
Peergroup
© BusinessWire
29.09.2025
LNTH
LISTED
NASDAQ
Johnson Fistel Announces Class Action Lawsuit Against Lantheus Holdings, Inc. (LNTH) on Behalf of Investors
News Preview
Johnson Fistel, PLLP announces that a class action lawsuit has commenced on behalf of investors of Lantheus Holdings, Inc. (NASDAQ: LNTH). The lawsuit seeks to recover losses on behalf of investors who purchased the Company’s securities between February 26, 2025 and August 5, 2025, inclusive (the “Class Period”).
What if I purchased Lantheus sec...
Themefolio
Profiler
Peergroup
© Globe Newswire
24.09.2025
LNTH
LISTED
NASDAQ
Lantheus and GE HealthCare Announce Exclusive Licensing Agreement for Prostate Cancer Imaging Agent PYLARIFY® (Piflufolastat F 18) in Japan
News Preview
BEDFORD, Mass. and CHICAGO and TOKYO, Sept. 24, 2025 (GLOBE NEWSWIRE) -- Lantheus Holdings, Inc. (NASDAQ: LNTH) and GE HealthCare (NASDAQ: GEHC) today announced an exclusive licensing agreement for GE HealthCare to develop, manufacture, and commercialize Lantheus’ piflufolastat F18 (PYLARIFY® in U.S. market) in Japan for prostate cancer diagnost...
Themefolio
Profiler
Peergroup
© BusinessWire
23.09.2025
LNTH
LISTED
NASDAQ
Lantheus Holdings, Inc. Sued for Securities Law Violations - Contact the DJS Law Group to Discuss Your Rights – LNTH
News Preview
The DJS Law Group reminds investors of a class action lawsuit against Lantheus Holdings, Inc. (“Lantheus” or “the Company”) (NASDAQ: LNTH) for violations of §§10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission.
Shareholders who purchased shares of LNTH durin...
Themefolio
Profiler
Peergroup
Advertisment
20.10.2025
© BusinessWire
18.09.2025
LNTH
LISTED
NASDAQ
Deadline Alert: Lantheus Holdings, Inc. (LNTH) Investors Who Lost Money Urged To Contact Glancy Prongay & Murray LLP About Securities Fraud Lawsuit
News Preview
Glancy Prongay & Murray LLP reminds investors of the upcoming November 10, 2025 deadline to file a lead plaintiff motion in the class action filed on behalf of investors who purchased or otherwise acquired Lantheus Holdings, Inc. (“Lantheus” or the “Company”) (NASDAQ: LNTH) securities between February 26, 2025 and August 5, 2025, inclusive (th...
Themefolio
Profiler
Peergroup
© BusinessWire
17.09.2025
LNTH
LISTED
NASDAQ
Deadline Approaching: Lantheus Holdings, Inc. (LNTH) Investors Who Lost Money Urged to Contact Law Offices of Howard G. Smith
News Preview
Law Offices of Howard G. Smith reminds investors of the upcoming November 10, 2025 deadline to file a lead plaintiff motion in the case filed on behalf of investors who purchased Lantheus Holdings, Inc. (“Lantheus” or the “Company”) (NASDAQ: LNTH) securities between February 26, 2025 and August 5, 2025, inclusive (the “Class Period”).
IF YOU ARE...
Themefolio
Profiler
Peergroup
© BusinessWire
16.09.2025
LNTH
LISTED
NASDAQ
Glancy Prongay & Murray LLP, a Leading Securities Fraud Law Firm, Encourages Lantheus Holdings, Inc. (LNTH) Investors To Inquire About Securities Fraud Class Action
News Preview
Glancy Prongay & Murray LLP, a leading national shareholder rights law firm, announces that a securities fraud class action lawsuit has been filed on behalf of investors who purchased or otherwise acquired Lantheus Holdings, Inc. (“Lantheus” or the “Company”) (NASDAQ: LNTH) securities between February 26, 2025 and August 5, 2025, inclusive (th...
Themefolio
Profiler
Peergroup
© BusinessWire
15.09.2025
LNTH
LISTED
NASDAQ
Law Offices of Frank R. Cruz Encourages Lantheus Holdings, Inc. (LNTH) Investors To Inquire About Securities Fraud Class Action
News Preview
The Law Offices of Frank R. Cruz announces that a class action lawsuit has been filed on behalf of investors who purchased Lantheus Holdings, Inc. (“Lantheus” or the “Company”) (NASDAQ: LNTH) securities between February 26, 2025 and August 5, 2025, inclusive (the “Class Period”). Lantheus investors have until November 10, 2025 to file a lead plain...
Themefolio
Profiler
Peergroup
© BusinessWire
15.09.2025
LNTH
LISTED
NASDAQ
Law Offices of Howard G. Smith Encourages Lantheus Holdings, Inc. (LNTH) Investors To Inquire About Securities Fraud Class Action
News Preview
Law Offices of Howard G. Smith announces that a class action lawsuit has been filed on behalf of investors who purchased Lantheus Holdings, Inc. (“Lantheus” or the “Company”) (NASDAQ: LNTH) securities between February 26, 2025 and August 5, 2025, inclusive (the “Class Period”). Lantheus investors have until November 10, 2025 to file a lead plainti...
Themefolio
Profiler
Peergroup
© BusinessWire
12.09.2025
LNTH
LISTED
NASDAQ
Securities Fraud Investigation Into Lantheus Holdings, Inc. (LNTH) Announced – Investors Who Lost Money Urged To Contact Glancy Prongay & Murray LLP, a Leading Securities Fraud Law Firm
News Preview
Glancy Prongay & Murray LLP, a leading national shareholder rights law firm, today announced that it has commenced an investigation on behalf of Lantheus Holdings, Inc. (“Lantheus” or the “Company”) (NASDAQ: LNTH) investors concerning the Company’s possible violations of the federal securities laws.
IF YOU ARE AN INVESTOR WHO LOST MONEY ON L...
Themefolio
Profiler
Peergroup
© BusinessWire
12.09.2025
LNTH
LISTED
NASDAQ
Lantheus Holdings, Inc. (LNTH) Investors Who Lost Money – Contact Law Offices of Howard G. Smith About Securities Fraud Investigation
News Preview
Law Offices of Howard G. Smith announces an investigation on behalf of Lantheus Holdings, Inc. (“Lantheus” or the “Company”) (NASDAQ: LNTH) investors concerning the Company’s possible violations of federal securities laws.
IF YOU ARE AN INVESTOR WHO SUFFERED A LOSS IN LANTHEUS HOLDINGS, INC. (LNTH), CONTACT THE LAW OFFICES OF HOWARD G. SMITH ABO...
Themefolio
Profiler
Peergroup
© BusinessWire
11.09.2025
LNTH
LISTED
NASDAQ
NASDAQ: LNTH: Kessler Topaz Meltzer & Check, LLP Announces the Filing of a Securities Class Action Lawsuit Against Lantheus Holdings, Inc.
News Preview
The law firm of Kessler Topaz Meltzer & Check, LLP (www.ktmc.com) informs investors that a securities class action lawsuit has been filed against Lantheus Holdings, Inc. (“Lantheus”) (NASDAQ: LNTH) on behalf of those who purchased or otherwise acquired Lantheus securities between February 26, 2025, and August 5, 2025, inclusive (the “Class Per...
Themefolio
Profiler
Peergroup
© BusinessWire
11.09.2025
LNTH
LISTED
NASDAQ
Securities Fraud Investigation Into Lantheus Holdings, Inc. (LNTH) Announced – Investors Who Lost Money Urged To Contact The Law Offices of Frank R. Cruz
News Preview
The Law Offices of Frank R. Cruz announces an investigation of Lantheus Holdings, Inc. (“Lantheus” or the “Company”) (NASDAQ: LNTH) on behalf of investors concerning the Company’s possible violations of federal securities laws.
IF YOU ARE AN INVESTOR WHO LOST MONEY ON LANTHEUS HOLDINGS, INC. (LNTH), CLICK HERE TO INQUIRE ABOUT POTENTIALLY PURSUI...
Themefolio
Profiler
Peergroup
© BusinessWire
11.09.2025
LNTH
LISTED
NASDAQ
LNTH INVESTOR ALERT: Robbins Geller Rudman & Dowd LLP Announces that Lantheus Holdings, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit
News Preview
The law firm of Robbins Geller Rudman & Dowd LLP announces that purchasers or acquirers of Lantheus Holdings, Inc. (NASDAQ: LNTH) securities between February 26, 2025 and August 5, 2025, inclusive (the “Class Period”), have until November 10, 2025 to seek appointment as lead plaintiff of the Lantheus class action lawsuit. Captioned Margolis v....
Themefolio
Profiler
Peergroup
© BusinessWire
11.09.2025
LNTH
LISTED
NASDAQ
Rosen Law Firm Urges Lantheus Holdings, Inc. (NASDAQ: LNTH) Stockholders with Losses in Excess of $100K to Contact the Firm for Information About Their Rights
News Preview
Rosen Law Firm, a global investor rights law firm, announces that a shareholder filed a class action on behalf of purchasers of securities of Lantheus Holdings, Inc. (NASDAQ: LNTH) between February 26, 2025 and August 5, 2025. Lantheus describes itself as a “global company that develops, manufactures, sells, and distributes certain diagnostic and...
Themefolio
Profiler
Peergroup
© BusinessWire
10.09.2025
LNTH
LISTED
NASDAQ
LNTH Investors Have Opportunity to Lead Lantheus Holdings, Inc. Securities Fraud Lawsuit with the Schall Law Firm
News Preview
The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against Lantheus Holdings, Inc. (“Lantheus” or “the Company”) (NASDAQ: LNTH) for violations of §§10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission....
Themefolio
Profiler
Peergroup
© BusinessWire
09.09.2025
LNTH
LISTED
NASDAQ
LNTH Alert: Kirby McInerney LLP Encourages Lantheus Holdings, Inc. Investors to Inquire about Investigation
News Preview
The law firm of Kirby McInerney LLP reminds investors its investigation on behalf of Lantheus Holdings, Inc. (“Lantheus” or the “Company”) (NASDAQ:LNTH) investors concerning the Company’s possible violation of the federal securities laws or other unlawful business practices.
[LEARN MORE ABOUT THE INVESTIGATION]
What Happened?
On August 6, 20...
Themefolio
Profiler
Peergroup
© BusinessWire
25.08.2025
LNTH
LISTED
NASDAQ
LNTH Investors Have Opportunity to Join Lantheus Holdings, Inc. Fraud Investigation with the Schall Law Firm
News Preview
The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Lantheus Holdings, Inc. (“Lantheus” or “the Company”) (NASDAQ: LNTH) for violations of the securities laws.
The investigation focuses on whether the Company issued false and/or misleading statements and/or faile...
Themefolio
Profiler
Peergroup
© Globe Newswire
22.07.2025
LNTH
LISTED
NASDAQ
Lantheus Completes Acquisition of Life Molecular Imaging and Appoints Dr. Ludger Dinkelborg as Head of R&D
News Preview
BEDFORD, Mass., July 22, 2025 (GLOBE NEWSWIRE) -- Lantheus Holdings, Inc. ("Lantheus" or the "Company") (NASDAQ: LNTH), today announced the successful completion of its previously disclosed acquisition of Life Molecular Imaging Ltd. ("Life Molecular"), a subsidiary of Life Healthcare Group Holdings Ltd ("Life Healthcare"). As part of the acquisit...
Themefolio
Profiler
Peergroup
© Globe Newswire
11.06.2025
LNTH
LISTED
NASDAQ
Lantheus Announces Presentations to be featured at the 2025 Society of Nuclear Medicine and Molecular Imaging (SNMMI) Annual Meeting
News Preview
BEDFORD, Mass., June 11, 2025 (GLOBE NEWSWIRE) -- Lantheus Holdings, Inc. (the Company) (NASDAQ: LNTH), the leading radiopharmaceutical-focused company committed to enabling clinicians to Find, Fight and Follow disease to deliver better patient outcomes, announced the presentation of new data highlighting two oncology radiodiagnostic agents will...
Themefolio
Profiler
Peergroup
© BusinessWire
07.05.2025
LNTH
LISTED
NASDAQ
Lantheus Holdings, Inc. Investigated for Securities Fraud Violations - Contact the DJS Law Group to Discuss Your Rights - LNTH
News Preview
The DJS Law Group announces that it is investigating claims on behalf of investors of Lantheus Holdings, Inc. (“Lantheus” or “the Company”) (NASDAQ: LNTH) for violations of the securities laws.
INVESTIGATION DETAILS: The investigation focuses on whether the Company issued misleading statements and/or failed to disclose information pertinent to in...
Themefolio
Profiler
Peergroup
© Globe Newswire
01.04.2025
LNTH
LISTED
NASDAQ
Lantheus Completes Acquisition of Evergreen Theragnostics
News Preview
BEDFORD, Mass., April 01, 2025 (GLOBE NEWSWIRE) -- Lantheus Holdings, Inc. (“Lantheus” or the “Company”) (NASDAQ: LNTH), the leading radiopharmaceutical-focused company committed to enabling clinicians to Find, Fight and Follow disease to deliver better patient outcomes, today announced that it has completed its previously announced acquisition o...
Themefolio
Profiler
Peergroup
© Globe Newswire
26.02.2025
LNTH
LISTED
NASDAQ
Lantheus Reports Fourth Quarter and Full Year 2024 Financial Performance
News Preview
BEDFORD, Mass., Feb. 26, 2025 (GLOBE NEWSWIRE) -- Lantheus Holdings, Inc. (Lantheus or the Company) (NASDAQ: LNTH), the leading radiopharmaceutical-focused company committed to enabling clinicians to Find, Fight and Follow disease to deliver better patient outcomes, today reported financial results for its fourth quarter and full year ended Decem...
Themefolio
Profiler
Peergroup
© Globe Newswire
21.02.2025
LNTH
LISTED
NASDAQ
Lantheus to Present at Upcoming Investor Conferences
News Preview
BEDFORD, Mass., Feb. 21, 2025 (GLOBE NEWSWIRE) -- Lantheus Holdings, Inc. (“Lantheus”) (NASDAQ: LNTH), the leading radiopharmaceutical-focused company committed to enabling clinicians to Find, Fight and Follow disease to deliver better patient outcomes, today announced members of its management team will present at the following upcoming investor...
Themefolio
Profiler
Peergroup
© Globe Newswire
12.02.2025
LNTH
LISTED
NASDAQ
Lantheus to Host Fourth Quarter and Full Year 2024 Earnings Conference Call and Webcast on February 26, 2025, at 8:00 a.m. Eastern Time
News Preview
BEDFORD, Mass., Feb. 12, 2025 (GLOBE NEWSWIRE) -- Lantheus Holdings, Inc. (the “Company”) (NASDAQ: LNTH) today announced that it will host a conference call and webcast at 8:00 a.m. ET on Wednesday, February 26, 2025, to discuss its financial and operating results for the fourth quarter and full year of 2024....
Themefolio
Profiler
Peergroup
© PR Newswire
28.01.2025
LNTH
LISTED
NASDAQ
Lantheus to Acquire Evergreen Theragnostics for Upfront Payment of $250 Million to Drive Strategic Evolution into Fully Integrated Radiopharmaceutical Leader
News Preview
Advances radiopharmaceutical leadership with addition of scalable manufacturing infrastructure and end-to-end clinical development capabilities
Adds OCTEVY™, a registrational-stage diagnostic asset, targeting neuroendocrine tumors that is complementary to Lantheus' therapeutic agent, PNT2003
Expands oncology radiopharmaceutical pipeline with mult...
Themefolio
Profiler
Peergroup
© Globe Newswire
28.01.2025
LNTH
LISTED
NASDAQ
Lantheus to Acquire Evergreen Theragnostics for Upfront Payment of $250 Million to Drive Strategic Evolution into Fully Integrated Radiopharmaceutical Leader
News Preview
Advances radiopharmaceutical leadership with addition of scalable manufacturing infrastructure and end-to-end clinical development capabilities...
Themefolio
Profiler
Peergroup
© Globe Newswire
13.01.2025
LNTH
LISTED
NASDAQ
Lantheus to Acquire Life Molecular Imaging for an Upfront Payment of $350 Million to Accelerate Innovation for Patients in the Growing Alzheimer’s Disease Radiodiagnostic Market
News Preview
Enhances Lantheus’ growth profile with Neuraceq®, a globally approved F-18 PET imaging agent used to detect beta-amyloid plaques in patients evaluated for Alzheimer’s Disease...
Themefolio
Profiler
Peergroup
© Globe Newswire
20.11.2024
LNTH
LISTED
NASDAQ
Lantheus Announces Share Repurchase Program
News Preview
BEDFORD, Mass., Nov. 20, 2024 (GLOBE NEWSWIRE) -- Lantheus Holdings, Inc. (Lantheus or the Company) (NASDAQ: LNTH), the leading radiopharmaceutical-focused company committed to enabling clinicians to Find, Fight and Follow disease to deliver better patient outcomes, announces that its board of directors has authorized a program to repurchase up t...
Themefolio
Profiler
Peergroup
© Globe Newswire
06.11.2024
LNTH
LISTED
NASDAQ
Lantheus Reports Third Quarter 2024 Financial Results
News Preview
BEDFORD, Mass., Nov. 06, 2024 (GLOBE NEWSWIRE) -- Lantheus Holdings, Inc. (Lantheus or the Company) (NASDAQ: LNTH), the leading radiopharmaceutical-focused company committed to enabling clinicians to Find, Fight and Follow disease to deliver better patient outcomes, today reported financial results for its third quarter ended September 30, 2024....
Themefolio
Profiler
Peergroup
© Globe Newswire
15.09.2024
LNTH
LISTED
NASDAQ
Lantheus Presents Results from the Primary Analysis of Phase 3 Pivotal SPLASH Trial in PSMA-Positive Metastatic Castration-Resistant Prostate Cancer During ESMO Congress 2024
News Preview
Study met its primary endpoint, demonstrating significant improvement in radiographic progression-free survival...
Themefolio
Profiler
Peergroup
© Globe Newswire
31.07.2024
LNTH
LISTED
NASDAQ
Lantheus Reports Second Quarter 2024 Financial Results
News Preview
Second Quarter 2024...
Themefolio
Profiler
Peergroup
© Globe Newswire
15.07.2024
LNTH
LISTED
NASDAQ
Lantheus Acquires NAV-4694, a Next-Generation ß Amyloid PET Imaging Agent for Alzheimer’s Disease
News Preview
Acquisition Expands Pipeline and Strengthens Alzheimer’s Diagnostic Capabilities Acquisition Expands Pipeline and Strengthens Alzheimer’s Diagnostic Capabilities...
Themefolio
Profiler
Peergroup
© Globe Newswire
10.07.2024
LNTH
LISTED
NASDAQ
Lantheus Welcomes CMS’ Proposed CY25 Rule for Improved Payment for Specialized Diagnostic Radiopharmaceuticals to Support Patient Access
News Preview
BEDFORD, Mass., July 10, 2024 (GLOBE NEWSWIRE) -- Lantheus Holdings, Inc. (“Lantheus”) (NASDAQ: LNTH), the leading radiopharmaceutical-focused company committed to enabling clinicians to Find, Fight and Follow disease to deliver better patient outcomes, announced that it welcomes the Centers for Medicare & Medicaid Services’ (CMS’) Proposed M...
Themefolio
Profiler
Peergroup
© Globe Newswire
27.06.2024
LNTH
LISTED
NASDAQ
Lantheus Acquires Global Rights to Life Molecular Imaging’s Novel Therapeutic and Diagnostic Pair Targeting GRPR for Prostate and Breast Cancers
News Preview
Deal Further Strengthens Lantheus’ Prostate Cancer Portfolio and Expands Pipeline to Include Breast Cancer Deal Further Strengthens Lantheus’ Prostate Cancer Portfolio and Expands Pipeline to Include Breast Cancer...
Themefolio
Profiler
Peergroup
© Globe Newswire
02.05.2024
LNTH
LISTED
NASDAQ
Lantheus Reports First Quarter 2024 Financial Results
News Preview
First Quarter 2024...
Themefolio
Profiler
Peergroup
Long/Short | Fractionals | Margin | Hedge · 4 powerful Trading App | MT4.MT5.ACTIVTRADER | TradingViewplus
More information, click here
More sector specific news
Your Press Release is missing or you want share news over GICS11? Drop us a line.
